Biopharma intelligence
Reading the market, not just the protocol
Clinical catalysts, regulatory milestones, financings, and M&A — the sponsor-side view that makes local execution advice worth taking.
Clinical catalysts
Readouts, milestones, and what moves on them
Regulatory milestones
Submission and approval timelines across markets
Financings
Who is funded, at what stage, and for how long
M&A
Competitive and consolidation analysis
Practice
Why a sponsor should care
Local execution advice is only worth taking from someone who understands the economics driving the decision.
At BPIQ & BiopharmIQ, a U.S.-based biopharma intelligence company, I analyse clinical catalysts, regulatory milestones, financings, and M&A.